Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 1987 Oct 10;16(33):1633-5.

[Antibioprevention in reconstructive arterial surgery. A double-blind study]

[Article in French]
Affiliations
  • PMID: 2959925
Clinical Trial

[Antibioprevention in reconstructive arterial surgery. A double-blind study]

[Article in French]
A Branchereau et al. Presse Med. .

Abstract

Routine antibiotic prophylaxis in reconstructive vascular surgery was established on a small number of controlled trials. A comparative double-blind study of cefazolin versus placebo was conducted in 179 patients who underwent reconstructive vascular surgery over a 23 month period. The surgical procedures were divided in three groups: aorto-iliac reconstructions (112 cases) infra-inguinal reconstructions (50 cases), extra anatomic by-passes (17 cases). The arterial diseases encountered and the systemic and local conditions in favour of infection were equal in the 2 randomized groups. Among the 93 patients who received cephazolin, 13 (13.97%) developed an infection which was systemic in 1 case and local in 12 cases; 1 amputation and 1 death were observed in this group. In the placebo group 26 patients among 86 (30.23%) developed an infection, systemic in 4 cases and local in 22 cases with 1 death and 1 amputation. Statistical analysis (chi-square test) showed a significant difference in favour of the active substance. A short time massive dose of antibiotic administered in the perioperative period is the best method to reduce the incidence of infection in this type of surgery.

PubMed Disclaimer

LinkOut - more resources